Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial caseinolytic protease P (ClpP) is a highly conserved serine protease found throughout bacteria as well as within mitochondria and chloroplasts of eukaryotes. In bacteria, it forms a self-compartmentalizing tetradecameric complex composed of two stacked heptameric rings that create a barrel-like structure with an internal catalytic chamber. Each subunit contains a Ser-His-Asp catalytic triad responsible for peptide bond hydrolysis. By itself, ClpP degrades short peptides; however, efficient degradation of larger proteins requires association with cognate ATP-dependent chaperones such as ClpA or ClpX. These chaperones unfold substrate proteins using ATP hydrolysis and translocate them into the central chamber for controlled degradation. ClpP plays an essential role in maintaining cellular protein homeostasis by removing misfolded or damaged proteins and regulating levels of key regulatory factors during stress responses. Disruption or dysregulation of its function impairs bacterial viability and virulence, making it an attractive target for novel antibacterial therapies. Several small-molecule modulators have been developed that either inhibit its activity—leading to toxic accumulation—or hyperactivate it—causing lethal uncontrolled protein breakdown. In summary, bacterial caseinolytic protease P is a validated therapeutic target classified as an enzyme/serine-protease involved primarily in infection-related disease mechanisms through its central role in bacterial survival and pathogenicity.
Inhibition of the proteolytic activity to prevent protein degradation, leading to accumulation of toxic proteins in bacteria and cell death; Activation/dysregulation causing uncontrolled protein degradation, also resulting in bacterial cell death by disrupting essential processes
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial caseinolytic protease P (ClpP).